A case of panitumumab containing chemotherapy causing interstitial lung disease: early recognition and treatment resulting in a good outcome. [electronic resource]
Producer: 20190528ISSN:- 1757-790X
- Adenocarcinoma -- drug therapy
- Adrenal Cortex Hormones -- therapeutic use
- Aged, 80 and over
- Antineoplastic Agents, Immunological -- adverse effects
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Camptothecin -- analogs & derivatives
- Colorectal Neoplasms -- drug therapy
- Early Diagnosis
- Early Medical Intervention
- Fluorouracil -- therapeutic use
- Humans
- Leucovorin -- therapeutic use
- Liver Neoplasms -- drug therapy
- Lung Diseases, Interstitial -- chemically induced
- Male
- Panitumumab -- adverse effects
- Radiography, Thoracic
- Tomography, X-Ray Computed
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.